Search for Indicators
Disparities Dashboard
View all indicators that include breakout data by topics such as race/ethnicity, age and gender.
Indicator Gauge Icon Legend
Legend Colors
Red is bad, green is good, blue is not statistically different/neutral.
Compared to Distribution
the value is in the best half of communities.
the value is in the 2nd worst quarter of communities.
the value is in the worst quarter of communities.
Compared to Target
meets target; 
does not meet target.
Compared to a Single Value
lower than the comparison value;
higher than the comparison value;
not statistically different from comparison value.
Trend
non-significant change over time; 
significant change over time; 
no change over time.
Compared to Prior Value
higher than the previous measurement period;
lower than the previous measurement period;
no statistically different change from previous measurement period.
Significantly better than the overall value
Significantly worse than the overall value
Significantly different than the overall value
No significant difference with the overall value
No data on significance available
State: Oregon
Health / Alcohol & Drug Use
Value
Compared to:
State: Oregon Adults who Binge Drink (CDC 500 Cities)
State: Oregon Adults who Binge Drink (CDC 500 Cities)
17.4%
(2018)
Compared to:
Prior Value
(18.1%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
15.1
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(23.5)
The regional value is compared to the national value.
Prior Value
(13.9)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
State: Oregon
Health / Cancer
Value
Compared to:
State: Oregon Age-Adjusted Death Rate due to Breast Cancer
State: Oregon Age-Adjusted Death Rate due to Breast Cancer
19.3
Deaths per 100,000 females
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(19.6)
The regional value is compared to the national value.
Prior Value
(19.6)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(15.3)
State: Oregon Age-Adjusted Death Rate due to Cancer
State: Oregon Age-Adjusted Death Rate due to Cancer
150.6
Deaths per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(149.4)
The regional value is compared to the national value.
Prior Value
(153.7)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(122.7)
State: Oregon Age-Adjusted Death Rate due to Colorectal Cancer
State: Oregon Age-Adjusted Death Rate due to Colorectal Cancer
12.3
Deaths per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(13.1)
The regional value is compared to the national value.
Prior Value
(12.6)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(8.9)
State: Oregon Age-Adjusted Death Rate due to Lung Cancer
State: Oregon Age-Adjusted Death Rate due to Lung Cancer
33.2
Deaths per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(35.0)
The regional value is compared to the national value.
Prior Value
(34.8)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(25.1)
State: Oregon Age-Adjusted Death Rate due to Prostate Cancer
State: Oregon Age-Adjusted Death Rate due to Prostate Cancer
20.3
Deaths per 100,000 males
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(18.8)
The regional value is compared to the national value.
Prior Value
(20.7)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(16.9)
State: Oregon All Cancer Incidence Rate
State: Oregon All Cancer Incidence Rate
419.2
Cases per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(442.3)
The regional value is compared to the national value.
Prior Value
(428.4)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Breast Cancer Incidence Rate
State: Oregon Breast Cancer Incidence Rate
128.8
Cases per 100,000 females
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(127.0)
The regional value is compared to the national value.
Prior Value
(130.6)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Cancer: Medicare Population
State: Oregon Cancer: Medicare Population
10.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(12.0%)
The regional value is compared to the national value.
Prior Value
(10.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Cervical Cancer Incidence Rate
State: Oregon Cervical Cancer Incidence Rate
6.6
Cases per 100,000 females
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(7.5)
The regional value is compared to the national value.
Prior Value
(6.8)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Colorectal Cancer Incidence Rate
State: Oregon Colorectal Cancer Incidence Rate
32.8
Cases per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(36.5)
The regional value is compared to the national value.
Prior Value
(33.7)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Lung and Bronchus Cancer Incidence Rate
State: Oregon Lung and Bronchus Cancer Incidence Rate
49.1
Cases per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(54.0)
The regional value is compared to the national value.
Prior Value
(51.3)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Mammography Screening: Medicare Population
State: Oregon Mammography Screening: Medicare Population
45.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(47.0%)
The regional value is compared to the national value.
Prior Value
(44.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Oral Cavity and Pharynx Cancer Incidence Rate
State: Oregon Oral Cavity and Pharynx Cancer Incidence Rate
12.2
Cases per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(11.9)
The regional value is compared to the national value.
Prior Value
(12.4)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Prostate Cancer Incidence Rate
State: Oregon Prostate Cancer Incidence Rate
94.4
Cases per 100,000 males
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(110.5)
The regional value is compared to the national value.
Prior Value
(96.4)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Diabetes
Value
Compared to:
State: Oregon Age-Adjusted Death Rate due to Diabetes
State: Oregon Age-Adjusted Death Rate due to Diabetes
23.5
Deaths per 100,000 population
(2015-2017)
Compared to:
US Value
(21.2)
The regional value is compared to the national value. The source for the national value is Centers for Disease Control and Prevention
Prior Value
(23.0)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Diabetes: Medicare Population
State: Oregon Diabetes: Medicare Population
19.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(24.0%)
The regional value is compared to the national value.
Prior Value
(19.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Disabilities
Value
Compared to:
State: Oregon Persons with a Cognitive Difficulty
State: Oregon Persons with a Cognitive Difficulty
6.7%
(2018-2022)
Compared to:
US Value
(5.3%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Persons with a Disability
State: Oregon Persons with a Disability
14.9%
(2018-2022)
Compared to:
US Value
(12.9%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Persons with a Hearing Difficulty
State: Oregon Persons with a Hearing Difficulty
4.6%
(2018-2022)
Compared to:
US Value
(3.6%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Persons with a Self-Care Difficulty
State: Oregon Persons with a Self-Care Difficulty
2.8%
(2018-2022)
Compared to:
US Value
(2.6%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Persons with a Vision Difficulty
State: Oregon Persons with a Vision Difficulty
2.4%
(2018-2022)
Compared to:
US Value
(2.4%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Persons with an Ambulatory Difficulty
State: Oregon Persons with an Ambulatory Difficulty
7.1%
(2018-2022)
Compared to:
US Value
(6.7%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Health Care Access & Quality
Value
Compared to:
State: Oregon Adults with Health Insurance: 18-64
State: Oregon Adults with Health Insurance: 18-64
91.3%
(2021)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
Prior Value
(90.5%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Persons with Health Insurance
State: Oregon Persons with Health Insurance
92.6%
(2021)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
Prior Value
(92.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(92.4%)
<div>AHS-01: Increase the proportion of people with health insurance <strong>(LEADING HEALTH INDICATOR)</strong></div>
State: Oregon Persons with Private Health Insurance Only
State: Oregon Persons with Private Health Insurance Only
52.8%
(2022)
Compared to:
US Value
(54.8%)
The regional value is compared to the national value.
Prior Value
(52.6%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Persons with Public Health Insurance Only
State: Oregon Persons with Public Health Insurance Only
26.9%
(2022)
Compared to:
US Value
(24.8%)
The regional value is compared to the national value.
Prior Value
(26.9%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Preventable Hospital Stays: Medicare Population
State: Oregon Preventable Hospital Stays: Medicare Population
1,812.0
Discharges per 100,000 Medicare enrollees
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(2,677.0)
The regional value is compared to the national value.
Prior Value
(1,799.0)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Health Information Technology
Value
Compared to:
State: Oregon Persons with an Internet Subscription
State: Oregon Persons with an Internet Subscription
93.0%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(91.0%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Heart Disease & Stroke
Value
Compared to:
37.9
Deaths per 100,000 population
(2015-2017)
Compared to:
US Value
(37.5)
The regional value is compared to the national value. The source for the national value is Centers for Disease Control and Prevention
Prior Value
(37.2)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(33.4)
State: Oregon Age-Adjusted Death Rate due to Heart Attack
State: Oregon Age-Adjusted Death Rate due to Heart Attack
35.5
Deaths per 100,000 population 35+ years
(2020)
Compared to:
Prior Value
(35.7)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Age-Adjusted Death Rate due to Heart Disease
State: Oregon Age-Adjusted Death Rate due to Heart Disease
133.6
Deaths per 100,000 population
(2015-2017)
Compared to:
US Value
(94.8)
The regional value is compared to the national value. The source for the national value is Centers for Disease Control and Prevention
Prior Value
(133.6)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Age-Adjusted Hospitalization Rate due to Heart Attack
State: Oregon Age-Adjusted Hospitalization Rate due to Heart Attack
20.9
Hospitalizations per 10,000 population 35+ years
(2020)
Compared to:
Prior Value
(25.7)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Atrial Fibrillation: Medicare Population
State: Oregon Atrial Fibrillation: Medicare Population
13.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(14.0%)
The regional value is compared to the national value.
Prior Value
(13.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Heart Failure: Medicare Population
State: Oregon Heart Failure: Medicare Population
10.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(11.0%)
The regional value is compared to the national value.
Prior Value
(10.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Hyperlipidemia: Medicare Population
State: Oregon Hyperlipidemia: Medicare Population
53.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(65.0%)
The regional value is compared to the national value.
Prior Value
(52.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Hypertension: Medicare Population
State: Oregon Hypertension: Medicare Population
56.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(65.0%)
The regional value is compared to the national value.
Prior Value
(55.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Ischemic Heart Disease: Medicare Population
State: Oregon Ischemic Heart Disease: Medicare Population
15.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(21.0%)
The regional value is compared to the national value.
Prior Value
(15.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Stroke: Medicare Population
State: Oregon Stroke: Medicare Population
4.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(6.0%)
The regional value is compared to the national value.
Prior Value
(4.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Immunizations & Infectious Diseases
Value
Compared to:
State: Oregon Age-Adjusted Death Rate due to Influenza and Pneumonia
State: Oregon Age-Adjusted Death Rate due to Influenza and Pneumonia
9.6
Deaths per 100,000 population
(2015-2017)
Compared to:
US Value
(14.3)
The regional value is compared to the national value. The source for the national value is Centers for Disease Control and Prevention
Prior Value
(9.0)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Flu Vaccinations: Medicare Population
State: Oregon Flu Vaccinations: Medicare Population
44.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(50.0%)
The regional value is compared to the national value.
Prior Value
(43.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Pneumonia Vaccinations: Medicare Population
State: Oregon Pneumonia Vaccinations: Medicare Population
6.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(8.0%)
The regional value is compared to the national value.
Prior Value
(5.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Mental Health & Mental Disorders
Value
Compared to:
State: Oregon Age-Adjusted Death Rate due to Suicide
State: Oregon Age-Adjusted Death Rate due to Suicide
18.2
Deaths per 100,000 population
(2015-2017)
Compared to:
US Value
(13.6)
The regional value is compared to the national value. The source for the national value is Centers for Disease Control and Prevention
Prior Value
(18.1)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(12.8)
<div>MHMD-01: Reduce the suicide rate <strong>(LEADING HEALTH INDICATOR)</strong></div>
State: Oregon Depression: Medicare Population
State: Oregon Depression: Medicare Population
16.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(16.0%)
The regional value is compared to the national value.
Prior Value
(16.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Older Adults
Value
Compared to:
State: Oregon Adults 65+ with a Hearing Difficulty
State: Oregon Adults 65+ with a Hearing Difficulty
16.2%
(2018-2022)
Compared to:
US Value
(13.7%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Adults 65+ with a Self-Care Difficulty
State: Oregon Adults 65+ with a Self-Care Difficulty
7.4%
(2018-2022)
Compared to:
US Value
(7.4%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Adults 65+ with a Vision Difficulty
State: Oregon Adults 65+ with a Vision Difficulty
5.8%
(2018-2022)
Compared to:
US Value
(6.0%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Adults 65+ with an Independent Living Difficulty
State: Oregon Adults 65+ with an Independent Living Difficulty
13.0%
(2018-2022)
Compared to:
US Value
(13.6%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Age-Adjusted Death Rate due to Alzheimer's Disease
State: Oregon Age-Adjusted Death Rate due to Alzheimer's Disease
34.1
Deaths per 100,000 population
(2015-2017)
Compared to:
US Value
(30.3)
The regional value is compared to the national value. The source for the national value is Centers for Disease Control and Prevention
Prior Value
(31.8)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Alzheimer's Disease or Dementia: Medicare Population
State: Oregon Alzheimer's Disease or Dementia: Medicare Population
5.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(6.0%)
The regional value is compared to the national value.
Prior Value
(5.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Other Conditions
Value
Compared to:
State: Oregon Chronic Kidney Disease: Medicare Population
State: Oregon Chronic Kidney Disease: Medicare Population
14.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(18.0%)
The regional value is compared to the national value.
Prior Value
(14.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Osteoporosis: Medicare Population
State: Oregon Osteoporosis: Medicare Population
10.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(11.0%)
The regional value is compared to the national value.
Prior Value
(10.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
31.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(35.0%)
The regional value is compared to the national value.
Prior Value
(30.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Prevention & Safety
Value
Compared to:
State: Oregon Age-Adjusted Death Rate due to Falls
State: Oregon Age-Adjusted Death Rate due to Falls
14.5
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(9.8)
The regional value is compared to the national value.
Prior Value
(14.5)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Age-Adjusted Death Rate due to Firearms
State: Oregon Age-Adjusted Death Rate due to Firearms
11.8
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(12.0)
The regional value is compared to the national value.
Prior Value
(11.6)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(10.7)
State: Oregon Age-Adjusted Death Rate due to Unintentional Injuries
State: Oregon Age-Adjusted Death Rate due to Unintentional Injuries
47.2
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(51.6)
The regional value is compared to the national value.
Prior Value
(44.8)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(43.2)
State: Oregon Age-Adjusted Death Rate due to Unintentional Poisonings
State: Oregon Age-Adjusted Death Rate due to Unintentional Poisonings
15.1
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(23.5)
The regional value is compared to the national value.
Prior Value
(13.0)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Respiratory Diseases
Value
Compared to:
40.2
Deaths per 100,000 population
(2015-2017)
Compared to:
US Value
(41.0)
The regional value is compared to the national value. The source for the national value is Centers for Disease Control and Prevention
Prior Value
(40.5)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Asthma: Medicare Population
State: Oregon Asthma: Medicare Population
6.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(7.0%)
The regional value is compared to the national value.
Prior Value
(6.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon COPD: Medicare Population
State: Oregon COPD: Medicare Population
9.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(11.0%)
The regional value is compared to the national value.
Prior Value
(9.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Health / Sexually Transmitted Infections
Value
Compared to:
State: Oregon Chlamydia Incidence Rate
State: Oregon Chlamydia Incidence Rate
367.3
Cases per 100,000 population
(2021)
Compared to:
U.S. States
The distribution is based on data from 42 U.S. states and the District of Columbia.
US Value
(495.5)
The regional value is compared to the national value.
Prior Value
(376.0)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Gonorrhea Incidence Rate
State: Oregon Gonorrhea Incidence Rate
146.5
Cases per 100,000 population
(2021)
Compared to:
U.S. States
The distribution is based on data from 49 U.S. states and the District of Columbia.
US Value
(214.0)
The regional value is compared to the national value.
Prior Value
(152.0)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Syphilis Incidence Rate
State: Oregon Syphilis Incidence Rate
22.3
Cases per 100,000 population
(2021)
Compared to:
U.S. States
The distribution is based on data from 49 U.S. states and the District of Columbia.
US Value
(16.2)
The regional value is compared to the national value.
Prior Value
(14.9)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Community / Crime & Crime Prevention
Value
Compared to:
State: Oregon Age-Adjusted Death Rate due to Homicide
State: Oregon Age-Adjusted Death Rate due to Homicide
3.1
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(6.6)
The regional value is compared to the national value.
Prior Value
(2.8)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(5.5)
<div>IVP-09: Reduce homicides <strong>(LEADING HEALTH INDICATOR)</strong></div>
State: Oregon
Community / Demographics
Value
Compared to:
State: Oregon Foreign Born Persons
State: Oregon Foreign Born Persons
9.8%
(2018-2022)
Compared to:
US Value
(13.7%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Total Population
State: Oregon Total Population
4,240,137
People
(2022)
Compared to:
Prior Value
(4,256,301)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Veteran Population
State: Oregon Veteran Population
7.8%
(2018-2022)
Compared to:
US Value
(6.6%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Community / Public Safety
Value
Compared to:
State: Oregon Age-Adjusted Death Rate due to Motor Vehicle Collisions
State: Oregon Age-Adjusted Death Rate due to Motor Vehicle Collisions
5.7
Deaths per 100,000 population
(2016-2020)
Compared to:
US Value
(2.6)
The regional value is compared to the national value.
Prior Value
(6.0)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
11.1
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(11.4)
The regional value is compared to the national value.
Prior Value
(11.0)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(10.1)
State: Oregon
Community / Transportation
Value
Compared to:
State: Oregon Households without a Vehicle
State: Oregon Households without a Vehicle
7.0%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(8.3%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Mean Travel Time to Work
State: Oregon Mean Travel Time to Work
23.3
Minutes
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(26.7)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Workers Commuting by Public Transportation
State: Oregon Workers Commuting by Public Transportation
3.0%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(3.8%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(5.3%)
State: Oregon Workers who Drive Alone to Work
State: Oregon Workers who Drive Alone to Work
67.1%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(71.7%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Workers who Walk to Work
State: Oregon Workers who Walk to Work
3.4%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(2.4%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Economy / Housing & Homes
Value
Compared to:
State: Oregon Overcrowded Households
State: Oregon Overcrowded Households
3.2%
(2018-2022)
Compared to:
US Value
(3.4%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Renters Spending 30% or More of Household Income on Rent
State: Oregon Renters Spending 30% or More of Household Income on Rent
50.9%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(49.9%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(25.5%)
State: Oregon
Economy / Income
Value
Compared to:
State: Oregon Median Household Income
State: Oregon Median Household Income
$76,632
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
($75,149)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Per Capita Income
State: Oregon Per Capita Income
$41,805
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
($41,261)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Economy / Poverty
Value
Compared to:
State: Oregon Children Living Below Poverty Level
State: Oregon Children Living Below Poverty Level
13.5%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(16.7%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon Families Living Below Poverty Level
State: Oregon Families Living Below Poverty Level
7.3%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(8.8%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon People 65+ Living Below Poverty Level
State: Oregon People 65+ Living Below Poverty Level
8.8%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(10.0%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon People 65+ Living Below Poverty Level (Count)
State: Oregon People 65+ Living Below Poverty Level (Count)
66,836
People
(2018-2022)
Compared to:
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon People Living Below Poverty Level
State: Oregon People Living Below Poverty Level
11.9%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(12.5%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(8.0%)
State: Oregon Youth not in School or Working
State: Oregon Youth not in School or Working
2.2%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(1.8%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Education / Educational Attainment
Value
Compared to:
State: Oregon People 25+ with a Bachelor's Degree or Higher
State: Oregon People 25+ with a Bachelor's Degree or Higher
35.5%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(34.3%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon People 25+ with a High School Diploma or Higher
State: Oregon People 25+ with a High School Diploma or Higher
91.6%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(89.1%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Oregon
Environmental Health / Built Environment
Value
Compared to:
State: Oregon Access to Parks
State: Oregon Access to Parks
90.4%
(2020)
Compared to:
Prior Value
(87.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
